Skip to content
Biodatica
Start free

Investigator

Eugene Yan-Ho Chan

DNA MEDICINE INSTITUTE · funded by NHLBI

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.1M

Summed across those awards.

First award
Sep 10, 2020

Latest Sep 10, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient Management

    $50k

    Sep 10, 2024NHLBIDNA MEDICINE INSTITUTENIH RePORTER · 11252219 (opens the source filing in a new tab)

  2. R44

    5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient Management

    $1.0M

    Sep 10, 2024NHLBIDNA MEDICINE INSTITUTENIH RePORTER · 11184232 (opens the source filing in a new tab)

  3. R44

    Hemophilia Point-of-Care Monitoring Device and App

    $1.0M

    Sep 10, 2020NHLBIDNA MEDICINE INSTITUTENIH RePORTER · 11045006 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources